Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease - Johns Hopkins University (ClinicalTrials.gov, 2026)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com